The role of pyrimidine dimers and non-dimer damage in the inactivation of Escherichia coli by UV radiation.
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The reaction of the bis-chelating ligand 1,2-bis(2,2'-bipyridine-6-yl)ethane (L) with the trinuclear species of formula [Mn(3)O(O(2)CR)(6)(py)(3)](ClO(4)) (R = Me (1); R = Et (2); R = Ph (3)) has afforded the new tetranuclear mixed-valent complexes [Mn(4)O(2)(O(2)CR)(4)L(2)](ClO(4))(2) (R = Me (4); R = Et (5); R = Ph (6)) and [Mn(4)O(2)(OMe)(3)(O(2)CR)(2)L(2)(MeOH)](ClO(4))(2) (R = Me (7); R = Et (8); R = Ph (9)). Complexes 4-6 were obtained in yields of 20%, 44%, and 37%, respectively. They are mixed-valent, with an average Mn oxidation state of +2.5. Complexes 7-9 were obtained in yields of 57%, 65%, and 70%, respectively. They are also mixed-valent, but with an average Mn oxidation state of +2.75. Complexes 4 x 2THF and 9 x 3MeOH x H(2)O crystallize in the triclinic space group P1 macro and contain [Mn(4)(mu(3)-O)(2)](6+) and [Mn(4)(mu(3)-O)(2)(mu-OMe)(2)](5+) cores, respectively, the latter being a new structural type in the family of Mn(4) complexes. Reactivity studies of 4-9 have shown that 4-6 can be converted into 7-9, respectively, and vice versa. The magnetic properties of 5 and 9 have been studied by dc and ac magnetic susceptibility techniques. Complex 5 displays antiferromagnetic coupling between its Mn ions resulting in a spin ground state of S = 0. Complex 9 also displays antiferromagnetic coupling, but the resulting ground state is S = (7)/(2), as confirmed by fitting magnetization versus field data collected for 9 at low temperatures, which gave S = (7)/(2), D = -0.77 cm(-1), and g = 1.79. Complex 9 exhibits a frequency-dependent out-of-phase ac susceptibility peak, indicative of the slow magnetization relaxation that is diagnostic of single-molecule magnetism behavior.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
According to the reconstitution instructions for the Neurolite labelling kit, the contents of vial A (containing the ligand) is dissolved in 3 ml of saline and 1 ml of the solution is added to vial B (containing 1 ml of phosphate buffer) to which 2 ml of 99Tc(m) generator eluate had previously been added. This implies that 2 out of 3 ml of the ligand solution is not used. We have investigated the radiochemical purity of 99Tc(m)-ECD reconstituted from fractions of the residual solution after storage in a freezer. Fractions of 0.25 ml or 0.5 ml were reconstituted with 1.11 GBq or 3.7 GBq 99Tc(m)-pertechnetate, respectively, after storage at -20 degrees C for periods ranging from 1 day to 4 weeks. In each test situation, except when 0.25 ml fractions were labelled with 3.7 GBq 99Tc(m), 99Tc(m)-ECD was obtained with a radiochemical purity > 95% up to 6 h after reconstitution, as determined using two-strip TLC and reverse-phase HPLC. The results demonstrate that residual portions of Neurolite kits can be efficiently labelled after fractionation and storage in a freezer.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.